IREN's $20.3 Billion Backlog Is Locked In — Turning It Into Revenue Is the Open Question
Published on 11/13/2026 at 19:11 | Editorial boerse-global.de
IREN shares fell 8.6% on the day, caught in a downdraft that swept the broader AI cloud sector after Nebius issued a soft outlook and flagged higher spending plans, according to media reports. But the sell-off only sharpens a company-specific test that was already underway: whether IREN can convert a vast, contractually secured order book into running revenue on a schedule it has now pushed back.
At the heart of that test sits a single number. IREN is targeting a fully contracted and financed annualized revenue run rate of more than US$4 billion — a milestone it has moved from the end of 2026 to January 2027, with the company acknowledging delivery could stretch into February. Management attributed the slip to a customer-requested design change and the timing of equipment availability from suppliers.
The demand side, at least, is not in dispute. IREN reported a revenue backlog of US$20.3 billion. In its latest quarterly figures, revenue came in at US$228 million, of which US$200 million was generated by the AI cloud business. Adjusted EBITDA reached US$66 million, against a net loss of US$263 million.
Should investors sell immediately? Or is it worth buying IREN?
Wall Street's response has been mixed rather than uniform. JPMorgan kept its "Overweight" rating, with analyst Richard Choe reaffirming the call. Cantor Fitzgerald had already cut its price target to $47 from $99 on November 6 while holding its "Overweight" stance. Two other research houses trimmed their targets that same day to a range of $30 to $65, maintaining "Neutral" and "Buy" ratings respectively. Reuters also reported on November 6 that some of IREN's infrastructure deliveries for Microsoft had been delayed.
Financing the build-out is the other half of the equation. IREN pegged its remaining planned capital expenditure for fiscal 2027 at $15 billion. Of that, the company expects $9 billion to come from cash on hand, committed GPU financing and prepayments, with a further $6 billion to be raised through financings and other sources, subject to market conditions. That leaves the expansion partly hostage to whether IREN can secure additional capital on workable terms — a dependency that becomes more pointed as skepticism toward heavy AI spending grows.
For investors, the two risks are intertwined rather than separate. If capacity is delivered late again, the revenue ramp arrives later; if financing simultaneously becomes harder to obtain, the build-out comes under pressure from both directions. The bullish case rests on the combination holding: demand stays contractually locked in, execution lands inside the revised window, and the expansion carries IREN to a more economically durable scale. Operational progress would also need to show up in the earnings line before a re-rating looks justified.
The near-term checkpoint is concrete. Hitting the annualized revenue run rate in January 2027 — or, on the company's own guidance, possibly February — would demonstrate that the existing contracts can actually produce the targeted revenue. Missing that window would force a fresh assessment of both the timeline and the funding path, leaving the large backlog as a demand argument still, but one tied to more demanding conditions for delivery.
Ad
IREN Stock: New Analysis - 13 November
Fresh IREN information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
